AzTrials
AzTrials

Children with Medical ComplexityBRIDGENCT06599398

Bridging Hospital to Home for Children with Medical Complexity and Their Families

An observational study of Children with Medical Complexity, run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) at 1 site in Netherlands.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this observational study is to evaluate an innovative pediatric transitional care unit called the Jeroen Pit Huis (JPH). The primary objective of our study is to investigate whether an intermediate stay between hospital and home in the JPH have a favourable effect on healthcare consumption, patient, parent… Read more about this study

Who is it for?
Ages 0 minutes to 18 years
Conditions the study is for
Children with Medical Complexity
What is being tested?
Jeroen Pit Huis
How many people
150 participants
Where
1 siteNetherlands
Study dates
1 Dec 2023to 1 Jun 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 minutes to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: The population exists of all children admitted to one of the four UMCs. The population will be predominantly CMC. CMC have one or more chronic conditions, functional limitations, high family identified needs, and a high use of healthcare resources [1]. Eligible participants fulfil all inclusion and no exclusion criteria.

Subject eligibility (or inclusion) criteria for this are as follows:

  1. Age: at term (older than 37 weeks corrected gestational age) and younger than 18 years
  2. Admitted to the hospital with (a deterioration of) a chronic complex condition (CCC) [30] and/or (expected) continuous dependence on technology after discharge (see ad 2 below).
  3. Expected need of specialized medical and/or allied health care after discharge
  4. A stable medical condition and/or a set treatment regimen (see below ad 4)
  5. Discharge home not yet possible due to organization-, care- or family circumstances (see below ad 5)
  6. Have given informed consent (consenting process is described in chapter 11.2 recruitment and consent)

Ad 2 chronic complex condition Fulfils criteria of a chronic complex condition (CCC) [30] and/or (expected) continuous dependence on technology after discharge.

A complex chronic condition (CCC) is defined according to Feudtner et al. (1) as "any medical condition that can be reasonably expected to last at least 12 months (unless death intervenes) and to involve either several different organ systems or one organ system severely enough to require specialty pediatric care and probably some period of hospitalization in a tertiary care center." Verlaat et al., updated the CCC list based on expert opinion [31]. A table of diagnosis classified as CCC can be found in appendix 1. An unknown but suspected complex and chronic condition, such as a child born with multiple congenital anomalies but lacking a unifying diagnosis, will be included.

Ad 4 stable medical condition

The patient is defined as being in a stable medical condition if there is:

  1. A patent, safe airway to remain in the home situation, whether or not by means of a trachea cannula
  2. Adequate respiration, whether or not by means of (intermittent) support with oxygen, non-invasive ventilation or invasive ventilation via a trachea cannula
  3. A neurologically stable condition that may include temporary neurological impairments (such as seizures) not interfering (potentially life-threatening) with other vital functions such as respiration or circulation
  4. Drug treatment that can be given at home where (if applicable): a nasogastric, duodenal or jejunal tube and/or a percutaneous endoscopic gastrostomy (PEG) tube is in situ, or if necessary, a 'home-proof' intravenous access is guaranteed
  5. In case of enteral tube feeding, the nasogastric, duodenal or jejunal tube and/or a percutaneous endoscopic gastrostomy (PEG) tube is in situ, and the feeding schedule may be built up, reduced or variable if there are no contraindications for this. In case of parenteral feeding, the parenteral nutrition home program must be organized according to the home situation.

Ad 5 organization-, care- or family circumstances include the lack of 1 or more of the following requirements for safe discharge home:

  1. A sustainable care plan using the four 'Medische Kindzorg Systeem' domains (medical, safety, development and social) has been drawn up that includes all four domains such as among others (Medical Child care System that is used in The Netherlands to structure medical child care in the home situation):
  • care needs
  • clear coordination of tasks and responsibilities of parents and healthcare professionals (primary, secondary and tertiary care).
  1. The necessary medical and nursing care support (such as a feeding pump, adequate home care).
  2. Parents know who to contact with questions about the organization of care (e.g. financial issues, wheelchair, municipality)
  3. Essential medical technology is available at home and can be used for care.
  4. Reimbursement of care at home is adequately arranged.
  5. The house is located and furnished in such a way that the child can stay in it safely (accessibility for emergency services, telephone contact with parents, technical facilities) Parents/informal carers are adequately trained to take care of the child in the home situation, that means that they:
  6. Master care in all areas (medical, nursing, technical, psychosocial)
  7. Obtain declaration of care competencies, in particular:
  • assessment for somatic deterioration
  • acting in emergency situations (e.g. seeking help, resuscitation and if applicable: cannula dislocation, PEG probe problems, docking of a seizure)
  • realizing when to call for help and whom to call for help
  1. Can obtain adequate telephone assistance (working telephone, English/Dutch speaking)
  2. Are psychologically and emotionally ready to deal with new home situation (according to care professionals)

A potential subject will be excluded from participation in this study if:

  1. The patient is in need of end-of-life care
  2. Existence of predominantly social/family issues without serious medical problems in the index child
  3. Patient with behavioural/psychiatric problems necessitating other type of care
  4. Patient requiring rehabilitation medical care
  5. Patients who are not directly discharged home from the hospital (except for the JPH (e.g. via de Boeg, Villa Expert Care))
  6. Contagious disease that requires strict isolation

Trial locations and contacts

1 site in 1 country.

Heleen N Haspels, Msc contact

0031624979529

h.n.haspels@amsterdamumc.nl

Clara Van Karnebeek, Prof. Dr. contact

c.d.vankarnebeek@amsterdamumc.nl

Netherlands1 site, 1 recruiting
  • Amsterdam University Medical Centre

    Amsterdam

    Clara van Karnebeek, Prof. Dr., c.d.vankarnebeek@amsterdamumc.nl

    Recruiting

Other trials in Netherlands

About this study

Official title: Bridging Hospital to Home for Children with Medical Complexity and Their Families: the Effectiveness of a Transitional Care Unit (the "Jeroen Pit Huis")

The goal of this observational study is to evaluate an innovative pediatric transitional care unit called the Jeroen Pit Huis (JPH). The primary objective of our study is to investigate whether an intermediate stay between hospital and home in the JPH have a favourable effect on healthcare consumption, patient, parent and family-relevant quantitative outcome measures, compared to discharge directly from a hospital ward. Parents will be asked to complete several questionnaires on three different time points (at discharge, 3 and 12 months of follow up).

Read the detailed description

Rationale: Children with Medical Complexities (CMC) often require 24/7 expert care for which often prolonged (re)admissions in a university medical centre (UMC) are necessary which, in turn, impedes discharge home. Hospital to home transitions of CMC is a multi-faceted process with many challenges and obstacles. This protocol describes the evaluation of an innovative Transitional Care Unit (TCU) called the Jeroen Pit Huis (JPH), that aims to supports this transition.

Hypothesis: We hypothesize that an intermediate stay between hospital and home in the JPH will have a favourable effect on healthcare consumption, patient, parent and family-relevant quantitative outcome measures, compared to discharge directly from a hospital ward.

Objective: The primary objective of our study is to investigate whether an intermediate stay between hospital and home in the JPH lowers parental distress compared to discharge directly from a hospital ward. Furthermore, the effect on quality of life (QoL) in children and parents, growth, family functioning, impact on parental employment, parental self-efficacy, anxiety, depression, sleep disturbance, posttraumatic stress (PTSD), care satisfaction, and healthcare consumption will be assessed with and without an intermediate stay in the JPH.

Study design: Multicenter quasi-experimental prospective cohort study

Study population: Patients (term newborns up to the age of 18 years) who; (1) are admitted in the hospital with (a deterioration of) a chronic complex condition (CCC) and/or have (expected) continuous dependence on technology after discharge; (2) require specialized medical and/or allied health care after discharge; (3) are medically stable and/or have a set treatment regime and; (4) are not yet ready to be discharged home due organization-, care- or family circumstances.

Intervention (if applicable): Not applicable, since the JPH is the standard of transitional care in the Amsterdam UMC.

Main study parameters/endpoints:

Primary outcome measure at TCU/hospital discharge, 3 and 12 months of follow-up

  1. Parental distress Secondary outcome measures
  2. Quality of Life of children at JPH/hospital discharge, 3 and 12 months of follow-up.
  3. Growth parameters (weight, length, head circumference) at study inclusion, JPH/hospital discharge, 3 and 12 months of follow-up.
  4. Impact of having a CMC on parents' Quality of Life and family functioning at JPH/hospital discharge, 3 and 12 months of follow-up
  5. Impact on parental employment at 12 months of follow-up
  6. Parental self-efficacy, anxiety, depression, sleep disturbance at JPH/hospital discharge, 3 and 12 months of follow-up.
  7. Parental Posttraumatic Stress Disorder (PTSD) at 3 and 12 months of follow-up
  8. Satisfaction of the parents with the received care at JPH/hospital discharge
  9. Healthcare consumption during 12 months of follow-up

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Subjects do not benefit personally from study participation. This non-therapeutic research with minors will have negligible risks. The main burden of participation in this study is the need to complete several questionnaires in total on three different time points. The expected required time-investment of the children and their caregivers is approximately 2.5 hours in total (around 50 minutes at 3 different time points). Furthermore, it requires time and effort from physicians to screen and patients for inclusion.

Being tested
Jeroen Pit Huis
Keywords
Children with Medical Complexity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Jeroen Pit HuisOther

    The JPH is a unique and innovative Transitional Care Unit (TCU) situated in close proximity of the AUMC. In this TCU, patients and their family reside in separate private home-like apartments. The families can stay while practising in, and adapting to, their new reality until they are ready to transition home. A multidisciplinary team of healthcare experts (nurses, psychosocial care workers, family counsellors, and paediatricians) are gradually guiding parents towards taking on the role of their child's primary caregiver. This process is guided by a newly developed seven phase care path.One condition for staying in the JPH is that one parent is always present. In this form (24/7 parental stay and nursing care directly available under the supervision of pediatricians) the JPH is unique in the Netherlands.

Study groups in NCT06599398
Study groupRoleWhat they receive
Intervention groupThe intervention group comprise patients and families who had an intermediate stay between hospital and home in the Jeroen Pit Huis (JPH)
Receives: Other: Jeroen Pit Huis
Control groupsThe control groups comprise patients and families who undergo the hospital to home transition directly from the hospital. This includes patients from the EMC, RUMC, and UMCG. Patients from the AUMC who transition directly from hospital to home without an intermediate stay in the JPH will also be included in the control group.
Receives: Other: Jeroen Pit Huis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Parental distress

    Distress Thermometer for Parents (DT-P)

    Measured: Baseline, 3 and 12 months of follow-up

Secondary outcomes (15)
  1. Quality of Life of children

    Generieke Patient Reported Outcome Measures (GPROM) voor Kinderen

    Measured: Baseline, 3 and 12 months of follow-up

  2. Growth weight parameters

    Weight in kilograms

    Measured: Study inclusion, baseline, 3 and 12 months of follow-up

  3. Growth length parameters

    height in meters

    Measured: Study inclusion, baseline, 3 and 12 months of follow-up

  4. Impact of having a CMC on parents' Quality of Life and family functioning

    PedsQL FiM

    Measured: Baseline, 3 and 12 months of follow-up

  5. Impact on parental employment

    Self-constructed questionnaire

    Measured: 12 months of follow-up

  6. Parental self-efficacy

    Parental Measure of Self-Efficacy Managing a Child's Medications and Treatments

    Measured: Baseline, 3 and 12 months of follow-up

  7. Parental anxiety

    The PROMIS v1.0 - Anxiety 4a

    Measured: Baseline, 3 and 12 months of follow-up

  8. Parental depression

    PROMIS v1.0 - Depression 4a short-forms

    Measured: Baseline, 3 and 12 months of follow-up

  9. Parental sleep disturbance

    Short form 4a PROMIS Sleep Disturbance (SD)

    Measured: Baseline, 3 and 12 months of follow-up

  10. Parental Posttraumatic Stress Disorder (PTSD)

    PCL-5

    Measured: 3 and 12 months of follow-up

  11. Satisfaction of the parents with the received care

    MPOC-20

    Measured: Baseline

  12. Healthcare consumption - Length of hospital stay

    Length of hospital stay in days

    Measured: During 12 months of follow-up

  13. Healthcare consumption - Number of (PICU) readmissions

    Number of (PICU) readmissions

    Measured: During 12 months of follow-up

  14. Healthcare consumption - Emergency department visits

    Emergency department visits

    Measured: During 12 months of follow-up

  15. Healthcare consumption - (un)planned outpatient visits

    (un)planned outpatient visits

    Measured: During 12 months of follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Sep 2024
  2. Study start1 Dec 2023
  3. Primary completion1 Jun 2025 (estimated)
  4. Study completion1 Jun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06599398
Sponsor's protocol ID
BRIDGE
Acronym
BRIDGE
Status last verified
Sep 2024
First submitted
15 Sep 2023
Last updated
19 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Haspels HN, Mikkers MC, Knoester H, Jansen NJG, Ahout IML, Maaskant JM, van de Riet L, Haverman L, Dulfer K, Haasnoot M, Alsem MW, de Hoog M, van Woensel JBM, Joosten KFM, van Karnebeek CD; Transitional Care Unit Consortium. Bridging hospital to home for children with medical complexity and their families: an observational prospective cohort study protocol to assess the effectiveness of an innovative transitional care unit in the Netherlands (BRIDGE study). BMJ Open. 2025 Apr 19;15(4):e093693. doi: 10.1136/bmjopen-2024-093693.

    PubMed 40254310

Questions about this trial

What is this clinical trial studying?

An observational study of Children with Medical Complexity, run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Heleen N Haspels, Msc (0031624979529, h.n.haspels@amsterdamumc.nl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Parental distress (time frame: Baseline, 3 and 12 months of follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06599398, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in